Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Dexcom also provided continuous glucose monitoring sensors at a discounted rate for this study. Note to editors: The author(s) declared the following potential conflicts of interest with respect ...

Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...

Abbott banks on glucose monitors, new launches to ride out China, currency hit Dexcom forecast total ... its over-the-counter continuous glucose monitoring system in the U.S., the company said ...

Secured Registered Developer access to the Dexcom API, enabling initial integration with continuous glucose monitoring (CGM) data. Building on this success, Glucoguard has committed to ...

Upgrading to Limited Access to the Dexcom API, allowing real-time access and analysis of blood glucose values from the Dexcom G6 and G7 Continuous ... glucose monitoring and delivery system ...

allowing real-time access and analysis of blood glucose values from the Dexcom G6 and G7 Continuous Glucose Monitors. Achieving these goals will result in a fully functional mobile app capable of ...